Three private companies are merging to create a new entity in the psychedelics space.
Exploring the companies and themes that make up this emerging and exciting new sector
Hollister Biosciences Inc. Announces Private Placement Financing of Up to $1.5 Million
Hollister Biosciences announces a private placement for CAD$1.5 million, expected to close by July 12, 2020.
MPV Exploration Inc. Announces Definitive Agreement for Amalgamation with Entheon Biomedical Corp and Financing
Entheon Biomedical announces a three-cornered amalgamation with MPV Exploration along with concurrent financing.
Psychedelics: A Better Way To Treat Depression
Psychedelic drugs represent a potentially enormous step forward in treating an epidemic for which there are currently no good treatment options.
Eleusis Looks For Alzheimer’s Breakthrough With Micro-Dosed LSD
Eleusis Therapeutics is a private psychedelics company that is turning a lot of heads with its research on micro-doses of LSD as a treatment for Alzheimer's.
Champignon Provides Corporate Update, Announces Name Change, Rebranding and Planned Spin Out
Champignon Brands is proposing changing its corporate name to Apotheosis Scientific Ltd, and announces a planned spin-off its consumer packaged goods (CPG) division.
Mydecine Innovations Group Inc. Signs Partnership Agreement With Applied Pharmaceutical Innovation
Mydecine announces research agreement with a leading pharmacology research institution.
Mydecine Innovations Inks Important Research Agreement
Mydecine's research agreement with the University of Alberta is a key stepping-stone in expediting its psilocybin-based drug development research.
Mira X Acquisition Corp. Announces Proposed Qualifying Transaction with Field Trip Psychedelics Inc
Field Trip Psychedelics is planning to go public via a "three-cornered" RTO.
What Does Field Trip Psychedelics Offer Investors?
Field Trip Psychedelics has just announced a letter of intent to go public via RTO.
New Wave Holdings Appoints Dr. Dennis McKenna to Psychedelic Research Advisory Board
New Wave Holdings Corp has added a recognized expert in psychedelic medicine to the company's Advisory Board.
GreenStar Biosciences Signs Agreement to Acquire 100% of Eleusian Biosciences Corp.
Greenstar Biosciences is entering the psychedelics space via its acquisition of Eleusian Biosciences Corp.